Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltegravir for Asymptomatic HTLV-1 Infection
NCT01620736Phase 2Withdrawn
- Sponsor
- Washington University School of Medicine
- Start
- Jan 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of raltegravir in Human T-lymphotropic virus type 1 infection, sponsored by Washington University School of Medicine. Planned start Jan 2012; status: withdrawn.
02
Drugs
raltegravir
03
Conditions
Human T-lymphotropic virus type 1 infection
Beyond the preview
Go deeper on NCT01620736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01620736.